Abstract | BACKGROUND: The present investigation was intended to further clarify the mechanisms involved in renal dysfunction following high-dose methotrexate (HD-MTX) treatment. PATIENTS AND METHODS: Fifty eight predominately pediatric patients [39 male, 19 female; mean age 12.3 years (range 2.2-34.1)] suffering from acute lymphoblastic leukemia (ALL, n = 28), Non Hodgkins lymphoma (NHL, n = 13), osteosarcoma (n = 8), malignant brain tumor (n = 6), or an ALL relapse (n = 3), were prospectively examined. In the course of 220 infusions of HD-MTX, glomerular and tubular renal function was determined by measuring proteinuria and glomerular filtration rate (GFR), as well as renal excretion of alpha-1-microglobulin (AMG) and N-acetyl-beta-D-glucosaminidase (NAG). It was investigated whether there were differences in MTX toxicity in dependence on the administered dose (1, 5, or 12 g/m(2) BSA), on the combination with other cytostatic agents ( ifosfamide or cyclophosphamide), on the metabolism of MTX into 7-OH-MTX, and on pre-treatment with MTX. RESULTS: The administration of HD-MTX has no direct tubulotoxic effect. The disturbance in glomerular function was dose dependently and indicated by an increase in proteinuria as well as by a decrease in GFR; all changes were completely reversible and did not correlate to the metabolism of MTX to 7-OH-MTX. Increasing the number of MTX therapeutic cycles did not increase the nephrotoxicity of MTX. CONCLUSION: MTX is not directly tubulotoxic. Its side effects on glomeruli are usually without clinical relevance.
|
Authors | Lutz Hempel, Joachim Misselwitz, Christian Fleck, Karim Kentouche, Christiane Leder, Dorothea Appenroth, Michael Rost, Felix Zintl |
Journal | Medical and pediatric oncology
(Med Pediatr Oncol)
Vol. 40
Issue 6
Pg. 348-54
(Jun 2003)
ISSN: 0098-1532 [Print] United States |
PMID | 12692801
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2003 Wiley-Liss, Inc. |
Chemical References |
- Antimetabolites, Antineoplastic
- Methotrexate
|
Topics |
- Adolescent
- Adult
- Antimetabolites, Antineoplastic
(administration & dosage, adverse effects, therapeutic use)
- Child
- Child, Preschool
- Female
- Glomerular Filtration Rate
(drug effects)
- Humans
- Infusions, Intravenous
- Kidney Diseases
(chemically induced, physiopathology)
- Kidney Tubules
(drug effects, pathology, physiology)
- Male
- Methotrexate
(administration & dosage, adverse effects, therapeutic use)
- Prospective Studies
- Proteinuria
(etiology)
|